Basolateral potassium membrane permeability of A6 cells and cell volume regulation.
The K+ permeabilities (86Rb(K) transport) of the basolateral membranes (JbK) of a renal cell line (A6) were compared under isosmotic and hypo-osmotic conditions (serosal side) to identify the various components involved in cell volume regulation. Changing the serosal solution to a hypo-osmotic one (165 mOsm) induced a fast transient increase in Cai (max < 1 min) and cell swelling (max at 3-5 min) followed by a regulatory volume decrease (5-30 min) and rise in the SCC (stabilization at 30 min). In isosmotic conditions (247 mOsm), the 86Rb(K) transport and the SCC were partially blocked by Ba2+, quinidine, TEA and glibenclamide, the latter being the least effective. Changing the osmolarity from isosmotic to hypo-osmotic resulted in an immediate (within the first 3-6 min) stimulation of the 86Rb(K) transport followed by a progressive decline to a stable value higher than that found in isosmotic conditions. A serosal Ca(2+)-free media or quinidine addition did not affect the initial osmotic stimulation of JbK but prevented its "secondary regulation", whereas TEA, glibenclamide and DIDS completely blocked the initial JbK increase. Under hypo-osmotic conditions, the initial JbK increase was enhanced by the presence of 1 mM of barium and delayed with higher concentrations (5 mM). In addition, cell volume regulation was fully blocked by quinidine, DIDS, NPPB and glibenclamide, while partly inhibited by TEA and calcium-free media. We propose that a TEA- and glibenclamide-sensitive but quinidine-insensitive increase in K+ permeability is involved in the very first phase of volume regulation of A6 cells submitted to hypo-osmotic media. In achieving cell volume regulation, it would play a complementary role to the quinidine-sensitive K+ permeability mediated by the observed calcium rise.
Ehrenfeld
J
J
Department of Cellular and Molecular Biology, Commissariat à l'Energie Atomique, Villefranche/Mer, France.
Raschi
C
C
Brochiero
E
E
D000818:Animals; D002118:Calcium / Q000378:metabolism; D002460:Cell Line; D002463:Cell Membrane Permeability / Q000187:drug effects; D048429:Cell Size; D005905:Glyburide / Q000494:pharmacology; D007473:Ion Channels / Q000187:drug effects / Q000378:metabolism; D017136:Ion Transport / Q000187:drug effects; D007668:Kidney / Q000166:cytology / Q000378:metabolism; D008954:Models, Biological; D009997:Osmotic Pressure; D011188:Potassium / Q000378:metabolism*; D011802:Quinidine / Q000494:pharmacology; D012413:Rubidium / Q000493:pharmacokinetics; D012964:Sodium / Q000378:metabolism; D019789:Tetraethylammonium; D013757:Tetraethylammonium Compounds / Q000494:pharmacology; D014982:Xenopus laevis
D007473:Ion Channels; D013757:Tetraethylammonium Compounds; D019789:Tetraethylammonium; D012964:Sodium; D011802:Quinidine; D012413:Rubidium; D011188:Potassium; D005905:Glyburide; D002118:Calcium